Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients

Ranan Rimón, Ilya Averbuch, Pablo Rozick, L. Fijman-Danilovich, Thomas Kara, Haim Dasberg, Richard P. Ebstein, Robert H. Belmaker

Research output: Contribution to journalArticlepeer-review

51 Scopus citations

Abstract

Serum and cerebrospinal fluid (CSF) levels of haloperidol were measured in 12 chronic neuroleptic-non-responsive schizophrenic patients after 1 month on 60 mg haloperidol daily and then again after 1 month on 120 mg haloperidol daily. Serum haloperidol and CSF haloperidol rose with increasing dose. Serum and CSF levels were significantly correlated. No clinical improvement was achieved despite the high serum and CSF drug levels.

Original languageEnglish
Pages (from-to)197-199
Number of pages3
JournalPsychopharmacology
Volume73
Issue number2
DOIs
StatePublished - 1 Apr 1981
Externally publishedYes

Keywords

  • Blood levels
  • CSF
  • Haloperidol
  • Pharmacokinetics

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients'. Together they form a unique fingerprint.

Cite this